ask="4.40"
ask_size="100"
average_daily_volume="470834"
bid="2.15"
bid_size="100"
book_value="3.74"
change="+0.11"
change_from_200_day_moving_average="1.97"
change_from_50_day_moving_average="-0.17"
change_from_52_week_high="-6.66"
change_From_52_week_low="0.83"
change_in_percent="+2.61%"
close="4.32"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="18915000"
high="4.40"
high_52_weeks="10.98"
last_trade_date="2/2/2017"
last_trade_price="4.32"
last_trade_size="1705"
last_trade_time="4:00pm"
low="4.17"
low_52_weeks="3.49"
market_capitalization="97.42M"
moving_average_200_day="2.35"
moving_average_50_day="4.49"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+84.18%"
percent_change_from_50_day_moving_average="-3.81%"
percent_change_from_52_week_high="-60.66%"
percent_change_from_52_week_low="+23.78%"
previous_close="4.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.13"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="6.55"
stock_exchange="NMS"
symbol="CASC"
volume="359193"
weeks_range_52="3.49 - 10.98"
